MX9707393A - Capsula de gelatina blanda con una cubierta de gelatina que comprende derivado de xantina. - Google Patents
Capsula de gelatina blanda con una cubierta de gelatina que comprende derivado de xantina.Info
- Publication number
- MX9707393A MX9707393A MX9707393A MX9707393A MX9707393A MX 9707393 A MX9707393 A MX 9707393A MX 9707393 A MX9707393 A MX 9707393A MX 9707393 A MX9707393 A MX 9707393A MX 9707393 A MX9707393 A MX 9707393A
- Authority
- MX
- Mexico
- Prior art keywords
- shell
- gelatin
- xanthine derivative
- soft gelatin
- soft
- Prior art date
Links
- 108010010803 Gelatin Proteins 0.000 title abstract 2
- 229920000159 gelatin Polymers 0.000 title abstract 2
- 239000008273 gelatin Substances 0.000 title abstract 2
- 235000019322 gelatine Nutrition 0.000 title abstract 2
- 235000011852 gelatine desserts Nutrition 0.000 title abstract 2
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical class O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 title 1
- 239000007903 gelatin capsule Substances 0.000 title 1
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 abstract 2
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 abstract 1
- 230000000202 analgesic effect Effects 0.000 abstract 1
- 229960001948 caffeine Drugs 0.000 abstract 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
- A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
- A61K9/4825—Proteins, e.g. gelatin
Abstract
La presente invencion se refiere a composiciones farmacéuticas mejoradas que contienen un analgésico encapsulado dentro de una cubierta de gelatina blanda, en donde dicha cubierta contiene un derivado de xantina, tal como cafeína.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08412627 | 1995-03-29 | ||
US08/412,627 US5641512A (en) | 1995-03-29 | 1995-03-29 | Soft gelatin capsule compositions |
PCT/US1996/002236 WO1996029997A1 (en) | 1995-03-29 | 1996-02-20 | Soft gelatin capsule with a gelatin shell comprising xanthine derivative |
Publications (2)
Publication Number | Publication Date |
---|---|
MX9707393A true MX9707393A (es) | 1997-11-29 |
MXPA97007393A MXPA97007393A (es) | 1998-07-03 |
Family
ID=
Also Published As
Publication number | Publication date |
---|---|
AU4988596A (en) | 1996-10-16 |
BR9607961A (pt) | 1998-07-14 |
CA2214399A1 (en) | 1996-10-03 |
WO1996029997A1 (en) | 1996-10-03 |
EP0817618A1 (en) | 1998-01-14 |
JPH11502838A (ja) | 1999-03-09 |
CA2214399C (en) | 2001-03-27 |
US5641512A (en) | 1997-06-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2214399A1 (en) | Soft gelatin capsule with a gelatin shell comprising xanthine derivative | |
GB9313329D0 (en) | Softgel capsule shell compositions | |
GB2222770B (en) | Pharmaceutical compositions containing cyclosporins | |
MY116535A (en) | New stable pharmaceutical preparation for producing propellant gas-free aerosols | |
AU3811089A (en) | Chewable, edible soft gelatin capsule | |
ZA964337B (en) | Pharmaceutical compositions containing irbesartan. | |
OA09080A (en) | Pressure capsule for spray can, and spray can which utilizes such a capsule. | |
NZ239921A (en) | Substituted xanthine derivatives; medicaments. | |
DE68905224D1 (de) | Transendoskopische implantatkapsel. | |
HUP9800034A2 (hu) | Propán-1,3-did-származékot tartalmazó külsőleg adagolható készítmény helyi alkalmazásra | |
ZA985456B (en) | Solid pharmaceutical composition containing benzofuran derivatives. | |
EP0345885A3 (en) | Gellan gum/gelatin blends | |
ZA89667B (en) | Novel cosmetic compositions containing an extract of the aerial parts of cichorium intybus l. | |
NZ300778A (en) | Quinoxalin-2-one, aza-quinoxalin-2-one and aza-quinolin-2-one derivatives and analogs; medicaments containing them | |
GB2331458A9 (en) | Solvent compositions for gelatin capsules | |
PL309282A1 (en) | Application of 2-amino-6-n-propyl-amino- 4,5,6,7-tetrahydrobenzothiasole (pramipexol) as an antidepressant | |
GB2298137B (en) | Soft gelatin capsules | |
TW360543B (en) | Encapsulated pharmaceutical composition | |
UA29452C2 (uk) | Пристрій для покриття лікарської палички фіксованого розміру оболонкою | |
AU2633297A (en) | Harpagoside-enriched extract from harpagophytum procumbens and processes for producing same | |
ZA966345B (en) | Gas capsule. | |
PL346774A1 (en) | Micronised pharmaceutical compositions | |
ZA943441B (en) | Detonator primer capsule. | |
DE69423643T2 (de) | Schäumende gelatinkapselfüllung | |
GB2309509B (en) | Improvements in gelatin capsules for use as projectiles |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration | ||
MM | Annulment or lapse due to non-payment of fees |